Cystic fibrosis

Could lower airway microbiota serve as a biomarker for CF progression?


Young adults with cystic fibrosis with low microbiome diversity in their sputum have a greater risk of early end-stage lung disease, a novel study finds. According to the researchers from the Canada their findings could be used to  identify patients with CF at increased risk of disease progression for more intensive monitoring and treatment. In ...

Already a member?

Login to keep reading.


OR
© 2018 the limbic